Philip Astley-Sparke insider trades

Open-market stock purchases and sales by Philip Astley-Sparke, Director at Replimune Group, Inc, from SEC Form 4 filings since Jan 27, 2017.

Recent trades

DateStockTradeValue
Aug 20, 2026REPL Replimune Group, IncSold (not open market)—
Jun 16, 2026ENGN enGene Therapeutics IncBought (not open market)—
May 18, 2026REPL Replimune Group, IncSold$89.7K
Apr 1, 2026REPL Replimune Group, IncBought (not open market)—
Apr 1, 2026REPL Replimune Group, IncBought (not open market)—
Feb 18, 2026REPL Replimune Group, IncSold (not open market)—

Companies traded

  • REPL Replimune Group, Inc: 25 sales, last Aug 20, 2026
  • ENGN enGene Therapeutics Inc: other filings, last Jun 16, 2026
  • QURE uniQure NV: 14 sales, last Mar 2, 2021

Get free alerts when Philip Astley-Sparke files a new trade →